August 2, 2021

InSysBio announces its participation in AAPS 2021 PHARMSCI 360 which is to be held in Pennsylvania Convention Center, Philadelphia, PA, and Online 17-20 October, 2021. InSysBio team is going to present the update at the Virtual Booth (VB1) and 2 posters in frames of the Conference, namely:

Monday, October 18, 202112:30 PM – 1:30 PM ET:

• M2103V “Prediction and Comparison of PD-1 Receptor Occupancy in the Tumor during the Treatment with Immune Checkpoint Inhibitors Utilizing PBPK/RO Model” by Dmitry Shchelokov, Oleg Demin Jr, Oleg Demin

Wednesday, October 20, 202112:30 PM – 1:30 PM E

• W4102V "Application of Immune Response Template to Develop QSP Model of COVID-19" by Oleg Demin, Veronika Musatova, Maria Kupriyanova, Anna Viktorenko

Visit our Virtual Booth (VB1) and follow our presenters!

The news is going to be updated.

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 120 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

Share